drugset
drugset / Trial / NCT04997590

Clinical Study of Umbilical Cord Blood Mononuclear Cells (UCB-MNCs) in the Treatment of Traumatic Fracture Healing

NCT04997590 ↗

Unknown 40 enrolled Qianfoshan Hospital Shandong Qilu Stem Cells Engineering Co., Ltd. · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to explore the effectiveness and safety of umbilical cord blood mononuclear cells in promoting traumatic fracture healing.

Timeline

Start
2020-12-10
Primary completion
2021-12-10
Completion
2022-12-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Staphylococcal Enterotoxin C Unknown 2 ml Other
Subject Umbilical cord blood mononuclear cells Cell therapy 1e+08 cells Other

Indications

No indication recorded.